Exploration the feasibility and additional value of [18F]FDG/[68Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [68Ga]Ga-FAPI-04

被引:1
|
作者
Zheng, Zhe [1 ,2 ,3 ,4 ]
He, Yibo [1 ,2 ,3 ,4 ]
Mao, Wujian [1 ,2 ,3 ,4 ]
Yu, Haojun [1 ,2 ,3 ,4 ]
Wu, Ha [1 ,2 ,3 ,4 ]
Yang, Runjun [1 ,2 ,3 ,4 ]
Gao, Huaping [1 ,2 ,3 ,4 ]
Hu, Pengcheng [1 ,2 ,3 ,4 ]
Shi, Hongcheng [1 ,2 ,3 ,4 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Nucl Med, Shanghai 200032, Peoples R China
[2] Shanghai Inst Med Imaging, Shanghai 200032, Peoples R China
[3] Fudan Univ, Nucl Med Inst, Shanghai 200032, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Canc Prevent & Treatment Ctr, Shanghai 200032, Peoples R China
关键词
2-[F-18]fluoro-2-deoxy-D-glucose; Fibroblast activation protein inhibitor; Positron emission tomography/Computed tomography; FAPI-weighted PET;
D O I
10.1007/s00259-024-06924-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To validate the feasibility of one-stop 2-[F-18]fluoro-2-deoxy-D-glucose ([F-18]FDG) and [Ga-68]Ga-fibroblast activation protein inhibitor-04 ([Ga-68]Ga-FAPI-04) dual-low-activity-tracer positron emission tomography/computed tomography (PET/CT) at 34 min post-injection of [Ga-68]Ga-FAPI-04 and explore its additional value. Methods: Thirty pairs of patients with suspected malignancies who underwent dual-tracer imaging were enrolled in this retrospective study. The images were reconstructed at 34-39 and 50-60 min after additional injection of [Ga-68]Ga-FAPI-04 (in one-stop FDG-FAPI PET/CT, named PETFDG, PETD34-39, and PETD50-60; in the 2-day protocol, named PETFDG', PETF34-39, and PETF50-60, respectively). Tumour-to-normal ratios (TNR) of lesions in PETFDG, PETD34-39, and PETD50-60 and TNR of lesions in PETF34-39 and PETF50-60 were evaluated separately. To evaluate the potential added value of one-stop FDG-FAPI PET/CT over the 2-day protocol, TNRs of PETFDG, PETD34-39, and PETD50-60 were compared with PETF34-39. The lesion detectability of the two imaging protocols was evaluated by chi-square test. Results: Comparing FAPI-weighted PET (PETD34-39 and PETD50-60) and single-tracer imaging (PETFDG) in one-stop FDG-FAPI PET/CT, TNRs of FAPI-weighted PET were higher than those of PETFDG. PETD34-39 and PETD50-60 showed similar performance in lesion detectability and TNRs (all P > 0.05). In the 2-day protocol, there are no statistically significant differences in TNRs of all lesions at PETF34-39 and PETF50-60. Comparing one-stop FDG-FAPI PET/CT with the 2-day protocol, TNRs of PETF34-39 were significantly higher than those of PETFDG but lower than those of PETD34-39 and PETD50-60. Lesion detectability in the one-stop FDG-FAPI PET/CT was higher than that in the 2-day protocol. The average radiation dose in one-stop FDG-FAPI PET/CT was significantly lower than that in the 2-day protocol (P<0.001). Conclusion: One-stop FDG-FAPI PET/CT at 34 min could provide sufficient information to meet clinical diagnosis and showed better lesion detectability than that in the 2-day protocol.
引用
收藏
页码:638 / 647
页数:10
相关论文
共 50 条
  • [31] [68Ga]Ga-FAPI-04 PET/CT imaging of a patient with neurosyphilis mimicking intracranial malignant tumor
    Liu, Hongjun
    Li, Chongjiao
    Xiao, Zhiwei
    Tian, Yueli
    Lu, Nan
    He, Yong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (13) : 4179 - 4180
  • [32] One-stop [18F]FDG and [68Ga]Ga-DOTAFAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study
    Liu, Guobing
    Wu, Jianmao
    Shi, Hongcheng
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [33] The feasibility of ultra-early and fast total-body [68 Ga]Ga-FAPI-04 PET/CT scan
    Chen, Ruohua
    Yang, Xinlan
    Yu, Xiaofeng
    Zhou, Xiang
    Ng, Yee Ling
    Chen, Yumei
    Li, Lianghua
    Zhou, Yun
    Huang, Gang
    Liu, Jianjun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (03) : 661 - 666
  • [34] Comparative in vivo biodistribution and dosimetry in non-human primate of the fibroblast activation protein radiotracers [68Ga]Ga-FAPI-04, [68Ga]Ga-FAPI-46 and [18F]FAPI-74
    Thuy Tran
    Bolin, Martin
    Dahl, Kenneth
    Johnstrom, Peter
    Mitran, Bogdan
    Siikanen, Jonathan
    Schou, Magnus
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S216 - S217
  • [35] Head-to-head Comparison of [68Ga]Ga-Fapi-04 and [18F]-FDG PET/CT in Evaluating the Extent of Disease in Gastric Adenocarcinoma
    Kuten, J.
    Levine, C.
    Shamni, O.
    Pelles, S.
    Wolf, I.
    Lahat, G.
    Mishani, E.
    Even-Sapir, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S114 - S115
  • [36] Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma
    Kuten, Jonathan
    Levine, Charles
    Shamni, Ofer
    Pelles, Sharon
    Wolf, Ido
    Lahat, Guy
    Mishani, Eyal
    Even-Sapir, Einat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (02) : 743 - 750
  • [37] [68Ga]Ga-FAPI-04 PET/CT imaging in signet-ring cell carcinoma of sigmoid colon
    Fu, Lilan
    Hu, Kongzhen
    Tang, Ganghua
    Wu, Hubing
    Zhou, Wenlan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (05) : 1690 - 1691
  • [38] One-stop [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study (vol 50, 3159, 2023)
    Liu, Guobing
    Mao, Wujian
    Yu, Haojun
    Hu, Yan
    Gu, Jianying
    Shi, Hongcheng
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (10) : 3159 - 3159
  • [39] A comparative study of [68Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in the diagnostic accuracy and resectability prediction of ovarian cancer
    Yun Xi
    Lili Sun
    Xiaoxia Che
    Xinyun Huang
    Hua Liu
    Qun Wang
    Hongping Meng
    Yuxin Miao
    Qian Qu
    Wangxi Hai
    Biao Li
    Weiwei Feng
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2885 - 2898
  • [40] Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma
    Jonathan Kuten
    Charles Levine
    Ofer Shamni
    Sharon Pelles
    Ido Wolf
    Guy Lahat
    Eyal Mishani
    Einat Even-Sapir
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 743 - 750